Cataya Bio
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $64M
Investors
- 7
About Cataya Bio
, aka Cataya Bio operates as a synthetic biology company that provides an advanced engineering biology platform and biomanufacturing. The company's team consists of executives from domestic and international synthetic biology leaders Amyris, Plum Bio and Evonik China, etc. Lishan Zhao, the founder and CEO of the company, once served for 14 years at Amyris, a US-based synthetic biology company, as Vice President of research and development and President of China, and he has over two decades of experience in engineering biology. The company uses synthetic biology technology and strain engineering, fermentation and extraction processes and high-throughput automation technologies, etc. to provide natural, green, sustainable and innovative raw material products, including terpenoids, amino acids and their derivatives, and oligosaccharides. It also engages in product development in the fields of personal care, food nutrition and pharmaceutical ingredients. The company's revenue is generated by providing synthetic biology services.
Who invested in Cataya Bio
7 investors across 3 rounds
See all investors in Cataya Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cataya Bio
Who invested in Cataya Bio?
Cataya Bio has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cataya Bio raised?
Cataya Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cataya Bio last raise money?
Cataya Bio's most recent round on record is a Series B, in Sep 2023.
What does Cataya Bio do?
, aka Cataya Bio operates as a synthetic biology company that provides an advanced engineering biology platform and biomanufacturing.
Where is Cataya Bio headquartered?
Cataya Bio is headquartered in Shanghai, China.
Which VCs invest in companies like Cataya Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Cataya Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cataya Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.